{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Subject(ID=65667L,Language='IT')","uri":"https://ws.parlament.ch/OData.svc/Subject(ID=65667L,Language='IT')","type":"itsystems.Pd.DataServices.DataModel.Subject"},"Meetings":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Meeting(ID=4976L,Language='IT')","uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4976L,Language='IT')","type":"itsystems.Pd.DataServices.DataModel.Meeting"},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4976L,Language='IT')/Sessions"}},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4976L,Language='IT')/Subjects"}},"ID":"4976","Language":"IT","MeetingNumber":11,"IdSession":5205,"SessionNumber":5,"SessionName":"Sessione autunnale 2024","Council":1,"CouncilName":"Consiglio nazionale","CouncilAbbreviation":"CN","Date":"\/Date(1727049600000)\/","Begin":"1430","Modified":"\/Date(1730299145900)\/","LegislativePeriodNumber":52,"PublicationStatus":"final","MeetingOrderText":"Undicesima seduta","SortOrder":11,"Location":"N"},"SubjectsBusiness":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20247746,IdSubject=65667L,Language='IT')","uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20247746,IdSubject=65667L,Language='IT')","type":"itsystems.Pd.DataServices.DataModel.SubjectBusiness"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20247746,IdSubject=65667L,Language='IT')/Subjects"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20247746,IdSubject=65667L,Language='IT')/Businesses"}},"IdSubject":"65667","BusinessNumber":20247746,"Language":"IT","BusinessShortNumber":"24.7746","Title":"Heure des questions.\nQuestion Freymond Sylvain.\nMaladie de la langue bleue.\nUn vaccin est n\u00e9cessaire!","SortOrder":1,"PublishedNotes":null,"Modified":"\/Date(1726768909560)\/","TitleDE":"Fragestunde.\nFrage Freymond Sylvain.\nBlauzungenkrankheit.\nWir brauchen einen Impfstoff!","TitleFR":"Heure des questions.\nQuestion Freymond Sylvain.\nMaladie de la langue bleue.\nUn vaccin est n\u00e9cessaire!","TitleIT":null}]},"Transcripts":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Transcript(ID=345229L,Language='IT')","uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=345229L,Language='IT')","type":"itsystems.Pd.DataServices.DataModel.Transcript"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=345229L,Language='IT')/Subjects"}},"MembersCouncil":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=345229L,Language='IT')/MembersCouncil"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=345229L,Language='IT')/Businesses"}},"ID":"345229","Language":"IT","IdSubject":"65667","VoteId":null,"PersonNumber":4238,"Type":1,"Text":"<pd_text><p>La maladie de la langue bleue est une \"\u00e9pizootie \u00e0 combattre\" au sens de l'ordonnance sur les \u00e9pizooties. Elle se transmet par la piq\u00fbre de petits moustiques, ce qui la rend difficile \u00e0 combattre. Pour \u00e9viter que, par l'interm\u00e9diaire de ses d\u00e9placements, un animal infect\u00e9 ne propage le virus dans des r\u00e9gions non touch\u00e9es, les exploitations test\u00e9es positives sont plac\u00e9es sous s\u00e9questre. Rentrer les animaux la nuit et utiliser des moustiquaires et des r\u00e9pulsifs \u00e0 insectes permet de r\u00e9duire la probabilit\u00e9 que des animaux de rente soient infect\u00e9s, car piqu\u00e9s.</p>\n<p>Le s\u00e9rotype 3 de la maladie de la langue bleue BTV-3 a \u00e9t\u00e9 d\u00e9tect\u00e9 pour la premi\u00e8re fois dans notre pays en ao\u00fbt 2024. Si les vaccins existants contre le s\u00e9rotype 3 ne prot\u00e8gent pas contre la maladie, ils permettent n\u00e9anmoins de r\u00e9duire les sympt\u00f4mes cliniques, contribuant ainsi \u00e0 limiter le nombre d'animaux morts. Ils ne sont toutefois pas autoris\u00e9s dans les Etats membres de l'Union europ\u00e9enne ni en Suisse. En raison de la situation d'urgence, certains Etats membres de l'UE autorisent n\u00e9anmoins l'utilisation de ces vaccins.</p>\n<p>L'Office f\u00e9d\u00e9ral de la s\u00e9curit\u00e9 alimentaire et des affaires v\u00e9t\u00e9rinaires (OSAV), Swissmedic et la branche mettent tout en oeuvre pour qu'un vaccin contre le BTV-3 soit disponible en Suisse. Deux des trois fabricants sont en contact avec Swissmedic au sujet de l'autorisation d'un vaccin. D\u00e8s qu'un fabricant aura d\u00e9pos\u00e9 une demande d'autorisation, Swissmedic sera en mesure de traiter celle-ci en priorit\u00e9 et selon une proc\u00e9dure acc\u00e9l\u00e9r\u00e9e. Si un vaccin contre le BTV-3 \u00e9tait autoris\u00e9 dans un Etat membre de l'Union europ\u00e9enne, l'OSAV pourrait \u00e9galement d\u00e9livrer une autorisation d'importation.</p>\n</pd_text>","MeetingCouncilAbbreviation":"N","MeetingDate":"20240923","MeetingVerbalixOid":3919,"IdSession":"5205","SpeakerFirstName":"Elisabeth","SpeakerLastName":"Baume-Schneider","SpeakerFullName":"Baume-Schneider Elisabeth","SpeakerFunction":"BR-F","CouncilId":99,"CouncilName":"Consiglio federale","CantonId":26,"CantonName":"Giura","CantonAbbreviation":"JU","ParlGroupName":null,"ParlGroupAbbreviation":null,"SortOrder":1,"Start":"\/Date(1727103372039)\/","End":"\/Date(1727103475442)\/","Function":"BR-F","DisplaySpeaker":true,"LanguageOfText":"FR","Modified":"\/Date(1774876775624)\/","StartTimeWithTimezone":"\/Date(1727103372040+0120)\/","EndTimeWithTimezone":"\/Date(1727103475443+0120)\/","VoteBusinessNumber":null,"VoteBusinessShortNumber":null,"VoteBusinessTitle":null}]},"ID":"65667","Language":"IT","IdMeeting":"4976","VerbalixOid":755433,"SortOrder":22,"Modified":"\/Date(1774876775619)\/"}}